Evaluating the mySugr app for adults with type 1 diabetes

Not Applicable

Completed

• Conditions: Type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12620000228987
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-24
• Study Completion: 2020-12-15
• Last Update Posted: 3 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

Inclusion criteria are: (1) a diagnosis of type 1 diabetes >1 year; (2) 18 years of age or older; (3) ability to speak, read and understand English and provide informed consent; (4) own an iOS or android smartphone that can download apps

Exclusion Criteria

Exclusion criteria are: (1) already using a diabetes app to manage their type 1 diabetes, (2) being pregnant.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycaemic control will be assessed by glycated haemoglobin (HbA1c) levels. This information is collected as part of standard care and will be obtained from patient medical records.[ HbA1c was collected at three time points: baseline, 12 weeks and 6 months (12-weeks was the primary outcome).]